logo

For the Inventor, By the Inventor

Riga, Latvia

Jsc Grindeks

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 44.4

Forward Citations = 7

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Ivars Kalvins (5 out of 15 patents)

silverMedal Maija Dambrova (5 out of 8 patents)

bronzeMedal Einars Loza (4 out of 18 patents)

4.  Edgars Liepins (4 out of 4 patents)

5.  Janis Kuka (4 out of 4 patents)

6.  Osvalds Pugovics (4 out of 4 patents)

7.  Solveiga Grinberga (4 out of 4 patents)

8.  Ilmars Stonans (3 out of 4 patents)

9.  Reinis Vilskersts (3 out of 3 patents)

10.  Inese Reine (2 out of 5 patents)

11.  Daina Lola (2 out of 2 patents)

12.  Ivars Kalvinsh (2 out of 7 patents)

13.  Armands Zandersons (2 out of 2 patents)

14.  Liga Zvejniece (1 out of 4 patents)

15.  Grigorijs Veinbergs (1 out of 2 patents)


9 patents:

1. 10351534 - Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease (2019-07-16),
2. 9573882 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease (2017-02-21),
3. 9278907 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease (2016-03-08),
4. 8940793 - 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease (2015-01-27),
5. 8791273 - [object Object] (2014-07-29),
6. 8492413 - Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer (2013-07-23),
7. 8431717 - [object Object] (2013-04-30),
8. 8119835 - Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid (2012-02-21),
9. 7902377 - Method for preparing medetomidine and its salts (2011-03-08),
Company Overview
JSC Grindeks is a pharmaceutical company based in Latvia, specializing in the development, manufacturing, and sales of pharmaceutical products. With a history dating back to 1991, the company has established itself as a leading provider of high-quality medications and active pharmaceutical ingredients. Grindeks' portfolio includes products for various therapeutic areas, including cardiology, neurology, and psychiatry. The company is committed to innovation and continuous improvement in order to increase the effectiveness and safety of its products.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#1 in Riga

#2 in Latvia

Riga, LV
Riga, Latvia

Jsc Grindeks

Forward Citations = 7

35 inventors:

goldMedal Ivars Kalvins (5 out of 15 patents)

silverMedal Maija Dambrova (5 out of 8 patents)

bronzeMedal Einars Loza (4 out of 18 patents)

4.  Edgars Liepins (4 out of 4 patents)

5.  Janis Kuka (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jsc Grindeks. Retrieved from https://idiyas.com/company/jsc-grindeks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…